• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Vaccinogen Inc

+ Add to Watchlist


2.3000 USD 0.1800 8.49%

As of 20:10:05 ET on 12/19/2014.

Snapshot for Vaccinogen Inc (VGEN)

Open: 2.3000 Day's Range: 2.3000 - 2.3000 Volume: 200
Previous Close: 2.1200 52wk Range: 2.1100 - 11.0000 1-Yr Rtn: -65.93%

Stock Chart for VGEN

No chart data available.
  • VGEN:US 2.3000
  • 1D
  • 1M
  • 1Y
Interactive VGEN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VGEN

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 78.26
Shares Outstanding (M) 34.03
30 Day Average Volume 5,320
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VGEN

No data available

Company Profile & Key Executives for VGEN

Vaccinogen Inc is a biotechnology company that researches combating cancer by using the body's own immune system. The Company develops immunotherapy products for solid tumors and is also involved in the commercialization of autologous tumor vaccine products.

Anders HalldinVice ChairmanAndrew L TussingPresident/CEO/CFO/COO
More Company Profile & Key Executives for VGEN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil